Blood Collection Tube Manufacturers

Elevate Your Product from Commodity to Strategic Infrastructure

The blood collection tube (BCT) market is increasingly price‑driven. Margins are pressured. Differentiation is limited.
DName‑iT enables manufacturers to embed a molecular identity layer directly into blood collection tubes — transforming them into traceable, quality‑assured components within the NGS workflow.

​

What We Add to Your Product Line

• Molecular Identity Integration

• Embed proprietary DNA barcodes into your tubes without altering downstream assay chemistry or laboratory protocols.

• Commercial Value Created

• Differentation Without Workflow Disruption

• Offer a premium feature that does not require labs to change their assay chemistry or sequencing platforms.

• IP‑Backed Licensing Opportunity

• Integrate patented molecular barcoding under licensing or co‑development agreements — creating long‑term strategic value.

• Premium Positioning in Regulated Segments

• Strengthen your offering for oncology, NIPT, MRD, and other high‑integrity genomic applications.

• Defensive Moat Against Price Competition

• Move beyond commodity pricing by offering embedded quality assurance infrastructure.